Download pdf
Research and Application of Hyperbaric Oxygen Chambers
- 1 Lucton School, Chongqing, China
* Author to whom correspondence should be addressed.
Abstract
Hyperbaric oxygen chamber is a medical device that improves the oxygenation capacity of human tissue by increasing the ambient pressure and oxygen concentration. It has been widely used in a variety of clinical treatments and other fields. This study aims to systematically evaluate the application effects of hyperbaric oxygen chambers in different medical fields, explore its potential therapeutic principles and analyze its future development. Through a literature review, the study focused on the application of hyperbaric oxygen chambers in decompression sickness, carbon monoxide poisoning, chronic diseases and burn injuries. The results showed that hyperbaric oxygen chambers can significantly promote tissue regeneration, reduce nerve damage, and improve the survival rate of patients with carbon monoxide poisoning. Beyond medical applications, hyperbaric oxygen therapy is gaining recognition in the fields of sports recovery, beauty, and wellness, where it is used to enhance athletic performance, improve skin quality, and promote overall health. The conclusion of this study is that hyperbaric oxygen chambers have broad clinical application prospects as an auxiliary treatment method. With ongoing advancements in artificial intelligence and big data, the future of hyperbaric oxygen chambers is likely to see more personalized and intelligent systems, enabling treatments tailored to individual patient needs. Additionally, the development of portable and home-use chambers will increase accessibility, allowing more patients to benefit from this therapy outside traditional medical settings.
Keywords
Structure, application, future development
[1]. Dana B.. (2024).Hyperbaric oxygen therapy. Online nursing continuing education, 178.
[2]. Kirby, J. P., Snyder, J., Schuerer, D. J., Peters, J. S., & Bochicchio, G. V. (2019). Essentials of hyperbaric oxygen therapy: 2019 review. Missouri medicine, 116(3), 176.
[3]. Lee, H. Y., Lee, Y., Kim, H., & Paik, J. H. (2024). Mechanical Improvement of Gas Monitoring System in Monoplace Hyperbaric Chamber to Advance the Safety and Efficacy. Medical Devices: Evidence and Research, 217-227.(2024).
[4]. Thom, S. R. (2011). Hyperbaric oxygen: its mechanisms and efficacy. Plastic and reconstructive surgery, 127, 131-141.
[5]. Silva, L. B., Dos Santos, P. G. S. T., da Costa Ribeiro, A., Travassos, R. M. C., Ataíde, J. P. L.,Guimarães, L. G., ... & Júnior, P. M. D. R. M. (2024). Comprehensive evaluation of hyperbaric oxygen therapy: Mechanisms, applications, and clinical implications. Lumen et virnus, 15(39), 2807-2823.
[6]. Lee, H. Y., Hyun, K. I. M., Yoonsuk, L. E. E., & PAIK, J. H. (2024). Safety Evaluation of Monoplace Hyperbaric Chamber and Clinical Characteristics of Hyperbaric Oxygen Therapy for Patients with Carbon Monoxide Poisoning. Poisoning. Preprints, 2024010109.
[7]. Weaver, L. K., Hopkins, R. O., Chan, K. J., Churchill, S., Elliott, C. G., Clemmer, T. P., & Morris, A. H. (2002). Hyperbaric oxygen for acute carbon monoxide poisoning. New England Journal of Medicine, 347(14), 1057-1067.
[8]. Sahni, T., Singh, P., & John, M. J. (2003). Hyperbaric oxygen therapy: current trends and applications. Journal-association of physicians of india, 51, 280-288.
Cite this article
Yang,X. (2024). Research and Application of Hyperbaric Oxygen Chambers. Theoretical and Natural Science,71,49-55.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of ICBioMed 2024 Workshop: Computational Proteomics in Drug Discovery and Development from Medicinal Plants
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).